1. Home
  2. EDR vs RGEN Comparison

EDR vs RGEN Comparison

Compare EDR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDR
  • RGEN
  • Stock Information
  • Founded
  • EDR 2009
  • RGEN 1981
  • Country
  • EDR United States
  • RGEN United States
  • Employees
  • EDR N/A
  • RGEN N/A
  • Industry
  • EDR Services-Misc. Amusement & Recreation
  • RGEN Medical/Dental Instruments
  • Sector
  • EDR Consumer Discretionary
  • RGEN Health Care
  • Exchange
  • EDR Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • EDR 9.3B
  • RGEN 7.6B
  • IPO Year
  • EDR 2021
  • RGEN N/A
  • Fundamental
  • Price
  • EDR $31.04
  • RGEN $160.51
  • Analyst Decision
  • EDR Hold
  • RGEN Buy
  • Analyst Count
  • EDR 8
  • RGEN 12
  • Target Price
  • EDR $27.86
  • RGEN $187.44
  • AVG Volume (30 Days)
  • EDR 1.3M
  • RGEN 521.6K
  • Earning Date
  • EDR 02-26-2025
  • RGEN 02-19-2025
  • Dividend Yield
  • EDR 0.77%
  • RGEN N/A
  • EPS Growth
  • EDR N/A
  • RGEN N/A
  • EPS
  • EDR N/A
  • RGEN N/A
  • Revenue
  • EDR $7,481,692,000.00
  • RGEN $633,513,000.00
  • Revenue This Year
  • EDR $18.47
  • RGEN $2.28
  • Revenue Next Year
  • EDR N/A
  • RGEN $9.88
  • P/E Ratio
  • EDR $106.78
  • RGEN N/A
  • Revenue Growth
  • EDR 41.66
  • RGEN N/A
  • 52 Week Low
  • EDR $23.14
  • RGEN $113.50
  • 52 Week High
  • EDR $31.49
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • EDR 57.38
  • RGEN 62.61
  • Support Level
  • EDR $30.25
  • RGEN $150.23
  • Resistance Level
  • EDR $31.05
  • RGEN $160.64
  • Average True Range (ATR)
  • EDR 0.42
  • RGEN 6.76
  • MACD
  • EDR -0.08
  • RGEN 1.14
  • Stochastic Oscillator
  • EDR 68.97
  • RGEN 80.27

About EDR Endeavor Group Holdings Inc.

Endeavor Group Holdings Inc is an entertainment, sports, and content company. It offers services through its integrated capabilities of talent representation, content development, content distribution and sales, event management, marketing and licensing, and direct-to-consumer offerings. It operates its business in four segments: Owned Sports Properties; Events, Experiences & Rights; sports; and Representation. The company generates the majority of its revenue from the Events, Experiences & Rights segment which provides services to a diverse portfolio of live events annually, including live sports events, fashion, art fairs and music, culinary and lifestyle festivals, and major attractions. Geographically the company generates the majority revenue from the United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: